Please ensure Javascript is enabled for purposes of website accessibility
Home > Information > BioSpotlight

p53 (TP53) Antibodies & Proteins — Tumor Suppressor Research

Release date: 2026-06-25  View count: 85

p53 needs no introduction. Encoded by the TP53 gene, it is the most frequently mutated gene in human cancer — altered in roughly half of all solid tumors. As a transcription factor, wild-type p53 responds to DNA damage, oncogene activation, and other stress signals by inducing cell cycle arrest, DNA repair, or apoptosis. When p53 is mutated, it typically loses this tumor-suppressive function and, in many cases, acquires oncogenic gain-of-function properties that actively promote tumor progression.

abinScience offers a uniquely deep p53 antibody panel that goes beyond standard detection: wild-type p53 antibodies for IHC, WB, and ELISA, mutant-specific antibodies targeting the R175H hotspot with flow cytometry conjugates, a phospho-p53 (pT18) antibody for DNA damage signaling studies, 2 VHH nanobodies for IP and compact-format detection, and recombinant p53 proteins (human and mouse) for assay development.

Why Mutant-Specific p53 Detection Matters

Standard anti-p53 antibodies detect both wild-type and mutant p53 protein. In many tumors, this is fine — missense mutations in TP53 stabilize the protein, causing it to accumulate to high levels that are easily detected by IHC as strong nuclear staining. But this "pan-p53" detection cannot tell you which mutation is present, or distinguish wild-type p53 stabilized by MDM2 inhibitor treatment from mutant p53 stabilized by loss of degradation.

The R175H mutation is the single most common TP53 hotspot — it accounts for approximately 6% of all p53 mutations across cancer types and is especially frequent in ovarian, colorectal, and breast cancers. R175H disrupts the zinc-binding domain, causing a dramatic conformational change that abolishes DNA binding and exposes neoantigenic surfaces not found on wild-type p53.

abinScience offers a recombinant antibody (clone F2) that specifically recognizes the R175H mutant conformation and does not cross-react with wild-type p53. This antibody is available in 5 conjugate formats (unconjugated + FITC/PE/APC/PerCP) for flow cytometry-based detection of mutant p53 in dissociated tumor cells and cell lines.

Available Products

Wild-Type p53 Detection Antibodies

For general p53 detection (wild-type + mutant) by IHC, WB, and ELISA.

Product Name Catalog No. Format Reactivity Applications
Anti-TP53/p53 Polyclonal Antibody HY039014 Polyclonal (Rabbit) Human, Monkey, Hamster WB, IHC, ELISA
Anti-TP53/p53 Monoclonal Antibody (1A487) HY039015 Monoclonal (Mouse) Human ELISA, IHC, WB
Anti-TP53/p53 Monoclonal Antibody (1A488) HY039025 Monoclonal (Mouse) Human ELISA, IHC, WB
Anti-TP53/p53 Recombinant Antibody (163.6#) HY039053 Recombinant Human ELISA, WB
Anti-Mouse TP53/p53 Recombinant Antibody (PAb242) MY039013 Recombinant Mouse ELISA, IF, IHC, IP, WB
Anti-Mouse TP53/p53 Polyclonal Antibody MY039014 Polyclonal (Rabbit) Mouse ELISA, IHC, WB

p53 R175H Mutant-Specific Antibodies

Clone F2 — specifically detects the R175H mutant conformation of p53. Does not cross-react with wild-type p53. Available in multiple flow cytometry conjugates for intracellular staining of mutant p53 in tumor cells.

Product Name Catalog No. Conjugate Applications
Anti-p53 (R175H) Recombinant Antibody (F2) HY039107 Unconjugated ELISA, FCM
Anti-p53 (R175H) Recombinant Antibody (F2), FITC HY039117 FITC ELISA, FCM
Anti-p53 (R175H) Recombinant Antibody (F2), PE HY039137 PE ELISA, FCM
Anti-p53 (R175H) Recombinant Antibody (F2), APC HY039147 APC ELISA, FCM
Anti-p53 (R175H) Recombinant Antibody (F2), PerCP HY039127 PerCP ELISA, FCM

Phospho-p53 & Nanobody Antibodies

Product Name Catalog No. Format Applications
Anti-Phospho-p53 (pT18) Recombinant Antibody HY039013 Phospho-specific IHC, IP, WB
Anti-p53 Recombinant Nanobody (SAA1165) HY039033 VHH Nanobody ELISA, IP
Anti-p53 Recombinant Nanobody (SAA0875) HY039023 VHH Nanobody ELISA

p53/TP53 Recombinant Proteins

Product Name Catalog No. Tag Species Applications
Human TP53/p53 Recombinant Protein HY039012 N-His Human SDS-PAGE, WB, ELISA, Immunogen
Human TP53/p53 Recombinant Protein HY039022 N-GST Human SDS-PAGE, WB, ELISA, Immunogen
Mouse TP53/p53 Recombinant Protein MY039012 N-His Mouse SDS-PAGE, WB, ELISA, Immunogen

p53 in IHC: What the Staining Pattern Tells You

p53 IHC is one of the most commonly ordered stains in surgical pathology research, but interpreting it requires understanding what you are actually seeing. The staining pattern reflects the mutation status of TP53 in the tissue:

Strong diffuse nuclear Suggests missense mutation (stabilized mutant protein accumulates). The most common IHC pattern in p53-mutant tumors.
Complete absence Suggests nonsense or frameshift mutation (truncated protein not detected by antibody) or homozygous deletion. The "null" pattern.
Wild-type pattern Scattered positive nuclei among negative cells — normal p53 turnover. Positive cells represent transient stabilization during cell cycle checkpoint activation.
Cytoplasmic staining Rare but can indicate specific mutations that impair nuclear localization, or antibody artifact. Verify with a second clone.

Note: IHC staining patterns are used as research surrogates for mutation analysis. Definitive mutation identification requires sequencing. All abinScience p53 products are for research use only.

Gene: TP53  |  UniProt: P04637 (Human)  |  Molecular weight: ~43.7 kDa (runs at ~53 kDa on SDS-PAGE due to proline-rich region)  |  Hotspot mutations: R175H, R248W, R273H, G245S, R249S

Studying the p53 pathway?

abinScience also offers antibodies and proteins for MDM2 (p53 E3 ubiquitin ligase), p21/CDKN1A (p53 transcriptional target), BAX (p53-induced pro-apoptotic effector), and p16/CDKN2A (tumor suppressor frequently co-altered with p53). Contact us for pathway panel design.

For research use only. Not intended for diagnostic or therapeutic use.

Recommendation

Get a free quote